Синдром диссеминированного внутрисосудистого свертывания крови - Макацария А.Д.
ISBN 5-8249-0078-7
Скачать (прямая ссылка):
229. Goodnight SH: Bleeding and intravascular clotting in malignancy: A review. Ann N Y Acad Sei 230:271, 1974 99. Graeff N, Kuhn W: The amniotic infection syndrome. In Coagulation Disorders in Obstetrics. Philadelphia, WB Saunders, 1980, pp 91-95
230. Grabowskie E.P.. Boor S.E., Laposata M. Platelet hyperaggregability and asp resictence in two Brothers with syndrome X: A non cyclo-oxygenase platelet fect.//Thomb.a.Haemost, -1997, suppl, - P.71-71.
231. Hamada S, Takishita Y, Tamura T, et al: Plasma exchange in a patient with postpartum HELLP syndrome. J Obstet Gynaecol Res 22:371, 1996
232. Hamilton pi, Stalker AL, Douglas AS. DIC a review. J Clin Pathol 1978; 31:608
233. Hellgren M, Hagnevik K, Robbe H: Severe acquired antithrombin HI deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy. Gynecol Obstet In-vest 16:107, 1983
234. Hoffman M, Cooper ST: Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 by two distinct mechanisms. Blood Cells MoI Dis 21:156,1995
235. Howie EJ, Owen CA The clinical pathology of intravascular coagulation. Bibl Haematol 1983; 49:217.
236. Ishibashi M, Ito N, Fujita M, et al: Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms. Cancer 73:191,1994
237. Jones SL: HELLP: A cry for laboratory assistance: A comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol MoI Hematol 11:147, 1998
489
238. Judich A, Kuriansky J, Engelberg 1, et al: Amniotic fluid embolism following blunt abdominal trauma in pregnancy. Injury 29:475, 1998
239. Karpatkin S: Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 51:307, 1978
240. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura. AmJ Dis Child 1940; 59:1063.
241. Khong TY: Expression of endothelin-1 in amniotic fluid embolism and possible pathophisiological mechanism. BrJ Obstet Gynaecol 105.802,1998
242. Lamy C, Sharshar T, Mas JL: Cerebrovaseular diseases in pregnancy and puerperium. Revue Neurol (Paris) 152:422, 1996
243. Lasch HG, Krecke HJ, Rodriques-Erdman R, et al. Verbrauch Ko-agulopathie (Pathogenese and Therapy). Folia Haematol NF 1961; 61:325.
244. Lerner RG, Nelson JC, Corines P, et al: Disseminated intravascular coagulation: Complication of LeVeen peritoneovenous shunts. JAMA 240:2064,1984
245. Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal antitissue factor antibody m chimpanzees. J Clin Invest 1994; 93:114.
246. Lipinski B, Gurewich B. The effect of leukopenia versus thrombocytopenia on endotoxin-induced intravascular coagulation. Thi-omb Res 1976; 8:403.
247. Locksmith GJ: Amniotic fluid embolism. Obstet Gynecol Clin North Am 26:435, 1999
248. Lunetta P, Penttila A: Immunohistochemical identification of syn-cytiotrophoblastic cells and megakaryocytes in pulmonary vessels in a fatal case of amniotic fluid embolism. Int j Legal Med 108:210, 1996
249. Marder VJ, Shulman HR, Carroll VVR: LIigh molecular weight derivatives of human fibrinogen produced by plasmin. 1. Physico-chemical and immunological characterization. ) Biol Chem 244:2111, 1969
250. Magann EF, Martin JN: Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 42:532, 1999
251. Maikwardt F: Development of hirudin as an antithrombotic agent. Semin Thromb Hemost 15:269, 1989
252. Mas JL, Lamy C: Stroke in pregnancy and the puerperium [review]. J Neurol 245:305, 1998
253. Matsumoto T, Nishijima Y, Teramura Y, et al: Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-do-main. Thromb Res 38:279, 1985
490
254. McGehee WG, Paul RH, Feinstein DI: Antithrombin III concentrate in the management of patients with acute fatty liver of pregnancy. Blood 66:282a, 1985
255. McKay DG. DIC: an intermediary mechanism of disease. New York: Harper-Hoeber, 1965:493
256. McKay DG. Intravascular coagulation acute and chronic, disseminated and local. Proc Inst Med Chic 1972; 29:159
257. Mclntyre J.A., Wagenknecht D.R., Sugi Т. Phospholipid binding plasma prote required for antiphospholipid antibody detection-on overviev Amer.J.Reprod.Immunol.,-1997.-37(l).-p. 101-110.
258. Mellanby J. The coagulation of blood. Part 2: the actions of snake venoms, peptone, and leech extract. J Physiol 1909; 38:441.
259. Messmore HL: Automation in coagulation testing: Clinical applications. Semin Thromb Hemost 9:335, 1983
260. Minna JD, Robboy SJ, Colman RW D/C in man Springfield, IL Charles C Thomas, 1974
261. Mjahed K, Hammamouchi B, Hammoudi D, et al: Critical analysis of hemostasis disorders in the course of eclampsia. Report of 106 cases. J Gynecol Obstet Biol Reprod (Paris) 27:607, 1998
262. Muller-Berghaus G: Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemo-stas 15:58,1989
